In our study, we showed the important role of NGAL as a new inflammatory biomarker, which, when measured simultaneously with other markers of inflammation (i.e., CRP, and IL-6), turned out to be helpful (apart from clinical examination and anamnestic data and those obtained from imaging studies) in the diagnosis of appendicitis. This evidence concerns the gene IL6 and appendicitis.